Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 17 de 17
Filtrar
1.
Vet Res ; 51(1): 3, 2020 Jan 10.
Artículo en Inglés | MEDLINE | ID: mdl-31924274

RESUMEN

Salmonellosis is the second most common food-borne zoonosis in the European Union, with pigs being a major reservoir of this pathogen. Salmonella control in pig production requires multiple measures amongst which vaccination may be used to reduce subclinical carriage and shedding of prevalent serovars, such as Salmonella enterica serovar Typhimurium. Live attenuated vaccine strains offer advantages in terms of enhancing cell mediated immunity and allowing inoculation by the oral route. However, main failures of these vaccines are the limited cross-protection achieved against heterologous serovars and interference with serological monitoring for infection. We have recently shown that an attenuated S. Enteritidis strain (ΔXIII) is protective against S. Typhimurium in a murine infection model. ΔXIII strain harbours 13 chromosomal deletions that make it unable to produce the sigma factor RpoS and synthesize cyclic-di-GMP (c-di-GMP). In this study, our objectives were to test the protective effects of ΔXIII strain in swine and to investigate if the use of ΔXIII permits the discrimination of vaccinated from infected pigs. Results show that oral vaccination of pre-weaned piglets with ΔXIII cross-protected against a challenge with S. Typhimurium by reducing faecal shedding and ileocaecal lymph nodes colonization, both at the time of weaning and slaughter. Vaccinated pigs showed neither faecal shedding nor tissue persistence of the vaccine strain at weaning, ensuring the absence of ΔXIII strain by the time of slaughter. Moreover, lack of the SEN4316 protein in ΔXIII strain allowed the development of a serological test that enabled the differentiation of infected from vaccinated animals (DIVA).


Asunto(s)
GMP Cíclico/análogos & derivados , Salmonelosis Animal/prevención & control , Vacunas contra la Salmonella/química , Salmonella enteritidis/inmunología , Factor sigma/deficiencia , Enfermedades de los Porcinos/prevención & control , Animales , Proteínas Bacterianas , GMP Cíclico/deficiencia , Salmonelosis Animal/microbiología , Porcinos , Enfermedades de los Porcinos/microbiología
2.
Infect Immun ; 82(3): 1017-29, 2014 Mar.
Artículo en Inglés | MEDLINE | ID: mdl-24343648

RESUMEN

The Staphylococcus aureus biofilm mode of growth is associated with several chronic infections that are very difficult to treat due to the recalcitrant nature of biofilms to clearance by antimicrobials. Accordingly, there is an increasing interest in preventing the formation of S. aureus biofilms and developing efficient antibiofilm vaccines. Given the fact that during a biofilm-associated infection, the first primary interface between the host and the bacteria is the self-produced extracellular matrix, in this study we analyzed the potential of extracellular proteins found in the biofilm matrix to induce a protective immune response against S. aureus infections. By using proteomic approaches, we characterized the exoproteomes of exopolysaccharide-based and protein-based biofilm matrices produced by two clinical S. aureus strains. Remarkably, results showed that independently of the nature of the biofilm matrix, a common core of secreted proteins is contained in both types of exoproteomes. Intradermal administration of an exoproteome extract of an exopolysaccharide-dependent biofilm induced a humoral immune response and elicited the production of interleukin 10 (IL-10) and IL-17 in mice. Antibodies against such an extract promoted opsonophagocytosis and killing of S. aureus. Immunization with the biofilm matrix exoproteome significantly reduced the number of bacterial cells inside a biofilm and on the surrounding tissue, using an in vivo model of mesh-associated biofilm infection. Furthermore, immunized mice also showed limited organ colonization by bacteria released from the matrix at the dispersive stage of the biofilm cycle. Altogether, these data illustrate the potential of biofilm matrix exoproteins as a promising candidate multivalent vaccine against S. aureus biofilm-associated infections.


Asunto(s)
Biopelículas/crecimiento & desarrollo , Inmunidad Humoral/inmunología , Infecciones Estafilocócicas/inmunología , Staphylococcus aureus/inmunología , Animales , Matriz Extracelular/genética , Matriz Extracelular/inmunología , Inmunidad Humoral/genética , Interleucina-10/genética , Interleucina-10/inmunología , Interleucina-17/genética , Interleucina-17/inmunología , Ratones , Proteómica/métodos , Infecciones Estafilocócicas/genética , Infecciones Estafilocócicas/microbiología , Staphylococcus aureus/genética , Transcripción Genética/genética , Transcripción Genética/inmunología
3.
PLoS Pathog ; 8(8): e1002843, 2012.
Artículo en Inglés | MEDLINE | ID: mdl-22876182

RESUMEN

The biofilm matrix, composed of exopolysaccharides, proteins, nucleic acids and lipids, plays a well-known role as a defence structure, protecting bacteria from the host immune system and antimicrobial therapy. However, little is known about its responsibility in the interaction of biofilm cells with host tissues. Staphylococcus aureus, a leading cause of biofilm-associated chronic infections, is able to develop a biofilm built on a proteinaceous Bap-mediated matrix. Here, we used the Bap protein as a model to investigate the role that components of the biofilm matrix play in the interaction of S. aureus with host cells. The results show that Bap promotes the adhesion but prevents the entry of S. aureus into epithelial cells. A broad analysis of potential interaction partners for Bap using ligand overlayer immunoblotting, immunoprecipitation with purified Bap and pull down with intact bacteria, identified a direct binding between Bap and Gp96/GRP94/Hsp90 protein. The interaction of Bap with Gp96 provokes a significant reduction in the capacity of S. aureus to invade epithelial cells by interfering with the fibronectin binding protein invasion pathway. Consistent with these results, Bap deficient bacteria displayed an enhanced capacity to invade mammary gland epithelial cells in a lactating mice mastitis model. Our observations begin to elucidate the mechanisms by which components of the biofilm matrix can facilitate the colonization of host tissues and the establishment of persistent infections.


Asunto(s)
Proteínas Bacterianas/metabolismo , Biopelículas , Mastitis/metabolismo , Glicoproteínas de Membrana/metabolismo , Infecciones Estafilocócicas/metabolismo , Staphylococcus aureus/fisiología , Animales , Adhesión Bacteriana/fisiología , Proteínas Bacterianas/genética , Chlorocebus aethiops , Modelos Animales de Enfermedad , Células Epiteliales/metabolismo , Células Epiteliales/patología , Femenino , Humanos , Lactancia , Glándulas Mamarias Animales/metabolismo , Glándulas Mamarias Animales/microbiología , Glándulas Mamarias Animales/patología , Mastitis/microbiología , Mastitis/patología , Glicoproteínas de Membrana/genética , Ratones , Infecciones Estafilocócicas/genética , Infecciones Estafilocócicas/patología , Células Vero
4.
J Bacteriol ; 195(3): 417-28, 2013 Feb.
Artículo en Inglés | MEDLINE | ID: mdl-23161026

RESUMEN

Cyclic di-GMP (c-di-GMP) is a secondary messenger that controls a variety of cellular processes, including the switch between a biofilm and a planktonic bacterial lifestyle. This nucleotide binds to cellular effectors in order to exert its regulatory functions. In Salmonella, two proteins, BcsA and YcgR, both of them containing a c-di-GMP binding PilZ domain, are the only known c-di-GMP receptors. BcsA, upon c-di-GMP binding, synthesizes cellulose, the main exopolysaccharide of the biofilm matrix. YcgR is dedicated to c-di-GMP-dependent inhibition of motility through its interaction with flagellar motor proteins. However, previous evidences indicate that in the absence of YcgR, there is still an additional element that mediates motility impairment under high c-di-GMP levels. Here we have uncovered that cellulose per se is the factor that further promotes inhibition of bacterial motility once high c-di-GMP contents drive the activation of a sessile lifestyle. Inactivation of different genes of the bcsABZC operon, mutation of the conserved residues in the RxxxR motif of the BcsA PilZ domain, or degradation of the cellulose produced by BcsA rescued the motility defect of ΔycgR strains in which high c-di-GMP levels were reached through the overexpression of diguanylate cyclases. High c-di-GMP levels provoked cellulose accumulation around cells that impeded flagellar rotation, probably by means of steric hindrance, without affecting flagellum gene expression, exportation, or assembly. Our results highlight the relevance of cellulose in Salmonella lifestyle switching as an architectural element that is both essential for biofilm development and required, in collaboration with YcgR, for complete motility inhibition.


Asunto(s)
Proteínas Bacterianas/metabolismo , Celulosa/metabolismo , GMP Cíclico/análogos & derivados , Salmonella enteritidis/metabolismo , Salmonella typhimurium/metabolismo , Oxidorreductasas de Alcohol/metabolismo , Proteínas Bacterianas/genética , GMP Cíclico/metabolismo , Flagelos/fisiología , Regulación Bacteriana de la Expresión Génica/fisiología , Movimiento/fisiología , Polisacáridos Bacterianos/metabolismo , Rotación , Salmonella enteritidis/citología , Salmonella enteritidis/genética , Salmonella typhimurium/citología , Salmonella typhimurium/genética , Transducción de Señal/fisiología
5.
J Bacteriol ; 194(14): 3708-22, 2012 Jul.
Artículo en Inglés | MEDLINE | ID: mdl-22582278

RESUMEN

The Rcs phosphorelay pathway is a complex signaling pathway involved in the regulation of many cell surface structures in enteric bacteria. In response to environmental stimuli, the sensor histidine kinase (RcsC) autophosphorylates and then transfers the phosphate through intermediary steps to the response regulator (RcsB), which, once phosphorylated, regulates gene expression. Here, we show that Salmonella biofilm development depends on the phosphorylation status of RcsB. Thus, unphosphorylated RcsB, hitherto assumed to be inactive, is essential to activate the expression of the biofilm matrix compounds. The prevention of RcsB phosphorylation either by the disruption of the phosphorelay at the RcsC or RcsD level or by the production of a nonphosphorylatable RcsB allele induces biofilm development. On the contrary, the phosphorylation of RcsB by the constitutive activation of the Rcs pathway inhibits biofilm development, an effect that can be counteracted by the introduction of a nonphosphorylatable RcsB allele. The inhibition of biofilm development by phosphorylated RcsB is due to the repression of CsgD expression, through a mechanism dependent on the accumulation of the small noncoding RNA RprA. Our results indicate that unphosphorylated RcsB plays an active role for integrating environmental signals and, more broadly, that RcsB phosphorylation acts as a key switch between planktonic and sessile life-styles in Salmonella enterica serovar Typhimurium.


Asunto(s)
Proteínas Bacterianas/metabolismo , Biopelículas/crecimiento & desarrollo , Regulación Bacteriana de la Expresión Génica/fisiología , Salmonella enteritidis/fisiología , Salmonella typhimurium/fisiología , Secuencia de Aminoácidos , Sustitución de Aminoácidos , Proteínas Bacterianas/genética , Escherichia coli/clasificación , Escherichia coli/metabolismo , Mutación , Fosforilación/fisiología , Transducción de Señal/fisiología
6.
Antimicrob Agents Chemother ; 56(12): 6256-66, 2012 Dec.
Artículo en Inglés | MEDLINE | ID: mdl-23006750

RESUMEN

Control of membrane permeability is a key step in regulating the intracellular concentration of antibiotics. Efflux pumps confer innate resistance to a wide range of toxic compounds such as antibiotics, dyes, detergents, and disinfectants in members of the Enterobacteriaceae. The AcrAB-TolC efflux pump is involved in multidrug resistance in Enterobacter cloacae. However, the underlying mechanism that regulates the system in this microorganism remains unknown. In Escherichia coli, the transcription of acrAB is upregulated under global stress conditions by proteins such as MarA, SoxS, and Rob. In the present study, two clinical isolates of E. cloacae, EcDC64 (a multidrug-resistant strain overexpressing the AcrAB-TolC efflux pump) and Jc194 (a strain with a basal AcrAB-TolC expression level), were used to determine whether similar global stress responses operate in E. cloacae and also to establish the molecular mechanisms underlying this response. A decrease in susceptibility to erythromycin, tetracycline, telithromycin, ciprofloxacin, and chloramphenicol was observed in clinical isolate Jc194 and, to a lesser extent in EcDC64, in the presence of salicylate, decanoate, tetracycline, and paraquat. Increased expression of the acrAB promoter in the presence of the above-described conditions was observed by flow cytometry and reverse transcription-PCR, by using a reporter fusion protein (green fluorescent protein). The expression level of the AcrAB promoter decreased in E. cloacae EcDC64 derivates deficient in SoxS, RobA, and RamA. Accordingly, the expression level of the AcrAB promoter was higher in E. cloacae Jc194 strains overproducing SoxS, RobA, and RamA. Overall, the data showed that SoxS, RobA, and RamA regulators were associated with the upregulation of acrAB, thus conferring antimicrobial resistance as well as a stress response in E. cloacae. In summary, the regulatory proteins SoxS, RobA, and RamA were cloned and sequenced for the first time in this species. The involvement of these proteins in conferring antimicrobial resistance through upregulation of acrAB was demonstrated in E. cloacae.


Asunto(s)
Proteínas Bacterianas/genética , Proteínas Bacterianas/fisiología , Proteínas Portadoras/biosíntesis , Proteínas Portadoras/genética , Enterobacter cloacae/genética , Enterobacter cloacae/metabolismo , Transactivadores/genética , Transactivadores/fisiología , Antibacterianos/farmacología , Proteínas Bacterianas/biosíntesis , Clonación Molecular , Medios de Cultivo , ADN Bacteriano/química , ADN Bacteriano/genética , Farmacorresistencia Microbiana/efectos de los fármacos , Ensayo de Cambio de Movilidad Electroforética , Enterobacter cloacae/efectos de los fármacos , Citometría de Flujo , Genes Reporteros , Prueba de Complementación Genética , Pruebas de Sensibilidad Microbiana , Datos de Secuencia Molecular , Plásmidos , Reacción en Cadena de la Polimerasa
7.
Proc Natl Acad Sci U S A ; 106(19): 7997-8002, 2009 May 12.
Artículo en Inglés | MEDLINE | ID: mdl-19416883

RESUMEN

Bacteria have developed an exclusive signal transduction system involving multiple diguanylate cyclase and phosphodiesterase domain-containing proteins (GGDEF and EAL/HD-GYP, respectively) that modulate the levels of the same diffusible molecule, 3'-5'-cyclic diguanylic acid (c-di-GMP), to transmit signals and obtain specific cellular responses. Current knowledge about c-di-GMP signaling has been inferred mainly from the analysis of recombinant bacteria that either lack or overproduce individual members of the pathway, without addressing potential compensatory effects or interferences between them. Here, we dissected c-di-GMP signaling by constructing a Salmonella strain lacking all GGDEF-domain proteins and then producing derivatives, each restoring 1 protein. Our analysis showed that most GGDEF proteins are constitutively expressed and that their expression levels are not interdependent. Complete deletion of genes encoding GGDEF-domain proteins abrogated virulence, motility, long-term survival, and cellulose and fimbriae synthesis. Separate restoration revealed that 4 proteins from Salmonella and 1 from Yersinia pestis exclusively restored cellulose synthesis in a c-di-GMP-dependent manner, indicating that c-di-GMP produced by different GGDEF proteins can activate the same target. However, the restored strain containing the STM4551-encoding gene recovered all other phenotypes by means of gene expression modulation independently of c-di-GMP. Specifically, fimbriae synthesis and virulence were recovered through regulation of csgD and the plasmid-encoded spvAB mRNA levels, respectively. This study provides evidence that the regulation of the GGDEF-domain proteins network occurs at 2 levels: a level that strictly requires c-di-GMP to control enzymatic activities directly, restricted to cellulose synthesis in our experimental conditions, and another that involves gene regulation for which c-di-GMP synthesis can be dispensable.


Asunto(s)
GMP Cíclico/análogos & derivados , Salmonella/genética , Animales , Fenómenos Fisiológicos Bacterianos , Biopelículas , Dominio Catalítico , GMP Cíclico/metabolismo , Eliminación de Gen , Regulación Bacteriana de la Expresión Génica , Ratones , Modelos Biológicos , Nucleótidos/química , Fenotipo , Estructura Terciaria de Proteína , Salmonella/metabolismo , Salmonella/patogenicidad , Transducción de Señal , Virulencia
8.
Infect Immun ; 78(7): 3217-25, 2010 Jul.
Artículo en Inglés | MEDLINE | ID: mdl-20457791

RESUMEN

Transcription of the Salmonella enterica recA gene is negatively controlled by the LexA protein, the repressor of the SOS response. The introduction of a mutation (recAo6869) in the LexA binding site, in the promoter region of the S. enterica ATCC 14028 recA gene, allowed the analysis of the effect that RecA protein overproduction has on the fitness of this virulent strain. The fitness of orally but not intraperitoneally inoculated recAo6869 cells decreased dramatically. However, the SOS response of this mutant was induced normally, and there was no increase in the sensitivity of the strain toward DNA-damaging agents, bile salts, or alterations in pH. Nevertheless, S. enterica recAo6869 cells were unable to swarm and their capacity to cross the intestinal epithelium was significantly reduced. The swarming deficiency in recAo6869 cells is independent of the flagellar phase. Moreover, swimming activity of the recAo6869 strain was not diminished with respect to the wild type, indicating that the flagellar synthesis is not affected by RecA protein overproduction. In contrast, swarming was recovered in a recAo6869 derivative that overproduced CheW, a protein known to be essential for this function. These data demonstrate that an equilibrium between the intracellular concentrations of RecA and CheW is necessary for swarming in S. enterica. Our results are the first to point out that the SOS response plays a critical role in the prevention of DNA damage by abolishing bacterial swarming in the presence of a genotoxic compound.


Asunto(s)
Genes Bacterianos/genética , Rec A Recombinasas/genética , Infecciones por Salmonella/microbiología , Salmonella enterica/patogenicidad , Administración Oral , Animales , Células CACO-2/microbiología , Femenino , Regulación Bacteriana de la Expresión Génica/genética , Genes Bacterianos/fisiología , Humanos , Íleon/microbiología , Inyecciones Intraperitoneales , Ratones , Ratones Endogámicos BALB C , Mutación , Reacción en Cadena de la Polimerasa de Transcriptasa Inversa , Salmonella enterica/genética
9.
Sci Rep ; 10(1): 17939, 2020 10 21.
Artículo en Inglés | MEDLINE | ID: mdl-33087792

RESUMEN

Infections caused by Staphylococcus aureus pose a serious and sometimes fatal health issue. With the aim of exploring a novel therapeutic approach, we chose GraXRS, a Two-Component System (TCS) that determines bacterial resilience against host innate immune barriers, as an alternative target to disarm S. aureus. Following a drug repurposing methodology, and taking advantage of a singular staphylococcal strain that lacks the whole TCS machinery but the target one, we screened 1.280 off-patent FDA-approved drug for GraXRS inhibition. Reinforcing the connection between this signaling pathway and redox sensing, we found that antioxidant and redox-active molecules were capable of reducing the expression of the GraXRS regulon. Among all the compounds, verteporfin (VER) was really efficient in enhancing PMN-mediated bacterial killing, while topical administration of such drug in a murine model of surgical wound infection significantly reduced the bacterial load. Experiments relying on the chemical mimicry existing between VER and heme group suggest that redox active residue C227 of GraS participates in the inhibition exerted by this FDA-approved drug. Based on these results, we propose VER as a promising candidate for sensitizing S. aureus that could be helpful to combat persistent or antibiotic-resistant infections.


Asunto(s)
Proteínas Bacterianas/antagonistas & inhibidores , Fármacos Fotosensibilizantes/farmacología , Fármacos Fotosensibilizantes/uso terapéutico , Infecciones Estafilocócicas/tratamiento farmacológico , Infecciones Estafilocócicas/microbiología , Staphylococcus aureus/genética , Infección de la Herida Quirúrgica/tratamiento farmacológico , Infección de la Herida Quirúrgica/microbiología , Verteporfina/farmacología , Verteporfina/uso terapéutico , Animales , Modelos Animales de Enfermedad , Reposicionamiento de Medicamentos , Humanos , Ratones , Terapia Molecular Dirigida , Neutrófilos/inmunología , Fagocitosis , Staphylococcus aureus/inmunología
10.
Front Pediatr ; 8: 589853, 2020.
Artículo en Inglés | MEDLINE | ID: mdl-33520889

RESUMEN

Introduction: Primary peritonitis (PP) and Ménétrier's Disease (MD) are both rare conditions among pediatric population. Although about 150 MD cases have been described in the scientific literature to date, its onset with a PP is an unusual condition. Case Presentation: We present a case of an 11-year-old boy who was admitted to our unit because of abdominal pain and distension. Complementary tests showed ascites, bilateral pleural effusion, leukocytosis, increased acute phase reactants and hypoproteinemia with hypoalbuminemia. Laparoscopy ruled out appendicitis or visceral perforations and exposed purulent peritoneal fluid, compatible with PP. Biochemical stool analysis showed increased clearance of alpha-1-antitrypsin, which was consistent with a protein-losing enteropathy. Gastroscopy findings were compatible with MD. The clinical course was favorable and he had no recurrence after 12 months of follow-up. Conclusion: PP can be the first clinical manifestation of pediatric MD. Knowledge of MD and its generally benign nature in children is important in order to avoid excessive testing and unnecessary treatment.

11.
Infect Immun ; 77(9): 3978-91, 2009 Sep.
Artículo en Inglés | MEDLINE | ID: mdl-19581398

RESUMEN

Staphylococcus aureus can establish chronic infections on implanted medical devices due to its capacity to form biofilms. Analysis of the factors that assemble cells into a biofilm has revealed the occurrence of strains that produce either a polysaccharide intercellular adhesin/poly-N-acetylglucosamine (PIA/PNAG) exopolysaccharide- or a protein-dependent biofilm. Examination of the influence of matrix nature on the biofilm capacities of embedded bacteria has remained elusive, because a natural strain that readily converts between a polysaccharide- and a protein-based biofilm has not been studied. Here, we have investigated the clinical methicillin (meticillin)-resistant Staphylococcus aureus strain 132, which is able to alternate between a proteinaceous and an exopolysaccharidic biofilm matrix, depending on environmental conditions. Systematic disruption of each member of the LPXTG surface protein family identified fibronectin-binding proteins (FnBPs) as components of a proteinaceous biofilm formed in Trypticase soy broth-glucose, whereas a PIA/PNAG-dependent biofilm was produced under osmotic stress conditions. The induction of FnBP levels due to a spontaneous agr deficiency present in strain 132 and the activation of a LexA-dependent SOS response or FnBP overexpression from a multicopy plasmid enhanced biofilm development, suggesting a direct relationship between the FnBP levels and the strength of the multicellular phenotype. Scanning electron microscopy revealed that cells growing in the FnBP-mediated biofilm formed highly dense aggregates without any detectable extracellular matrix, whereas cells in a PIA/PNAG-dependent biofilm were embedded in an abundant extracellular material. Finally, studies of the contribution of each type of biofilm matrix to subcutaneous catheter colonization revealed that an FnBP mutant displayed a significantly lower capacity to develop biofilm on implanted catheters than the isogenic PIA/PNAG-deficient mutant.


Asunto(s)
Adhesinas Bacterianas/fisiología , Biopelículas , Infecciones Relacionadas con Catéteres/etiología , Infecciones Estafilocócicas/etiología , Staphylococcus aureus/fisiología , Acetilglucosamina/fisiología , Proteínas Bacterianas/fisiología , Humanos , Polisacáridos Bacterianos/fisiología , Respuesta SOS en Genética , Transactivadores/fisiología
12.
Rev. esp. quimioter ; 37(2): 170-175, abr. 2024. tab
Artículo en Español | IBECS (España) | ID: ibc-231651

RESUMEN

Introducción. Los objetivos de este trabajo fueron conocer la prevalencia de infecciones por Staphylococcus aureus resistente a meticilina (SARM) en la población pediátrica de nuestro departamento de salud, describir los factores de riesgo para infección por SARM frente a las producidas por S. aureus sensible a meticilina (SASM) y conocer el perfil de sensibilidad antibiótica de los aislados de SARM y SASM. Pacientes y métodos. Se realizó un estudio retrospectivo descriptivo y analítico de las infecciones producidas por SARM frente a las producidas por SASM durante los años 2014 al 2018. Se estudiaron las variables predictoras de SARM mediante un modelo de regresión logística binaria. Resultados. Se identificaron 162 pacientes con infecciones por S. aureus, 15,4% resistentes a meticilina. Los porcentajes mayores de infección por SARM se dieron entre los niños que precisaron ingreso hospitalario (23,4%). En el análisis univariante alcanzaron significación estadística la necesidad de ingreso hospitalario, el antecedente de haber recibido tratamiento antibiótico en los 3 meses previos, el tipo de infección y el antecedente de infección o colonización previa por SARM. En el modelo de regresión logística la necesidad de ingreso hospitalario y el tratamiento antibiótico reciente mantuvieron significación estadística. Solo recibieron tratamiento antibiótico correcto el 26,7% de los niños que ingresaron con infección por SARM. Conclusiones. Nuestros resultados sugieren la necesidad de revisar las pautas de tratamiento empírico usando fármacos activos frente a SARM en las infecciones de probable origen estafilocócico que ingresen en el hospital en niños sobre todo si han recibido tratamiento antibiótico reciente. (AU)


Introduction. The objectives of this work were to know the prevalence of methicillin-resistant S. aureus (MRSA) infections in the paediatric population of our health department, to describe the risk factors for infection by MRSA compared to those produced by methicillin-susceptible S. aureus (MSSA) and to know the antibiotic sensitivity profile of MRSA and MSSA isolates. Material and methods. A retrospective, descriptive and analytical study of infections produced by MRSA versus those produced by MSSA was carried out during the years 2014 to 2018. Risk factors for MRSA infection were studied using a binary logistic regression model. Results, 162 patients with S. aureus infections were identified. Of these, 25 (15.4%) were MRSA. The highest percentages of MRSA infection occurred among children who required hospital admission (23.4%). In the univariate analysis the need of hospital admission, antibiotic treatment in the last 3 months, the kind of infection and past MRSA infection or colonisation reached statistical significance. However, only the need of hospital admission and antibiotic treatment in the last 3 months maintained statistical significance in the binary logistic regression model. Correct antibiotic treatment was only prescribed in 26.7% of the MRSA infection cases admitted to the hospital. Conclusions. Our results suggest the need to review empirical local treatment regimen using drugs active against MRSA in infections of probable staphylococcal origin admitted to the hospital, especially if they have received antibiotic treatment in the last 3 months. (AU)


Asunto(s)
Humanos , Niño , Staphylococcus aureus , Resistencia a la Meticilina , Factores de Riesgo , Prevalencia , Hospitalización , Estudios Retrospectivos , Epidemiología Descriptiva
13.
C R Biol ; 329(11): 849-57, 2006 Nov.
Artículo en Inglés | MEDLINE | ID: mdl-17067927

RESUMEN

Although exopolysaccharides are important and often essential compounds of the biofilm matrix, recent evidences suggest that a group of surface proteins plays a leading role during the development of the microbial communities. The first member of this group of proteins was described in a Staphylococcus aureus bovine mastitis isolate and was named Bap, for biofilm-associated protein. Later on, other surface proteins homologous to Bap and involved in biofilm development have been described in many gram-positive and gram-negative bacteria. In this review, we have summarized our knowledge about three members of this group of proteins: Bap of S. aureus, Esp of Enterococcus faecalis and BapA of Salmonella enterica ser. Enteritidis.


Asunto(s)
Proteínas Bacterianas/química , Proteínas Bacterianas/inmunología , Biopelículas , Animales , Bovinos , Enterococcus faecalis/química , Enterococcus faecalis/inmunología , Mastitis Bovina/microbiología , Salmonella enterica/química , Salmonella enterica/inmunología , Staphylococcus aureus/química , Staphylococcus aureus/genética , Staphylococcus aureus/patogenicidad , Virulencia/fisiología
14.
PLoS One ; 11(8): e0161216, 2016.
Artículo en Inglés | MEDLINE | ID: mdl-27537839

RESUMEN

Salmonellosis is one of the most important bacterial zoonotic diseases transmitted through the consumption of contaminated food, with chicken and pig related products being key reservoirs of infection. Although numerous studies on animal vaccination have been performed in order to reduce Salmonella prevalence, there is still a need for an ideal vaccine. Here, with the aim of constructing a novel live attenuated Salmonella vaccine candidate, we firstly analyzed the impact of the absence of cyclic-di-GMP (c-di-GMP) in Salmonella virulence. C-di-GMP is an intracellular second messenger that controls a wide range of bacterial processes, including biofilm formation and synthesis of virulence factors, and also modulates the host innate immune response. Our results showed that a Salmonella multiple mutant in the twelve genes encoding diguanylate cyclase proteins that, as a consequence, cannot synthesize c-di-GMP, presents a moderate attenuation in a systemic murine infection model. An additional mutation of the rpoS gene resulted in a synergic attenuating effect that led to a highly attenuated strain, referred to as ΔXIII, immunogenic enough to protect mice against a lethal oral challenge of a S. Typhimurium virulent strain. ΔXIII immunogenicity relied on activation of both antibody and cell mediated immune responses characterized by the production of opsonizing antibodies and the induction of significant levels of IFN-γ, TNF-α, IL-2, IL-17 and IL-10. ΔXIII was unable to form a biofilm and did not survive under desiccation conditions, indicating that it could be easily eliminated from the environment. Moreover, ΔXIII shows DIVA features that allow differentiation of infected and vaccinated animals. Altogether, these results show ΔXIII as a safe and effective live DIVA vaccine.


Asunto(s)
Proteínas Bacterianas/fisiología , GMP Cíclico/análogos & derivados , Salmonelosis Animal/prevención & control , Vacunas contra la Salmonella/uso terapéutico , Salmonella typhimurium , Factor sigma/fisiología , Administración Oral , Animales , GMP Cíclico/deficiencia , Femenino , Interferón gamma/sangre , Interleucina-10/sangre , Interleucina-17/sangre , Interleucina-2/sangre , Ratones , Ratones Endogámicos BALB C , Salmonelosis Animal/inmunología , Vacunas contra la Salmonella/administración & dosificación , Vacunas contra la Salmonella/inmunología , Salmonella typhimurium/inmunología , Factor de Necrosis Tumoral alfa/sangre , Vacunas Atenuadas/administración & dosificación , Vacunas Atenuadas/inmunología , Vacunas Atenuadas/uso terapéutico
15.
Antimicrob Agents Chemother ; 51(9): 3247-53, 2007 Sep.
Artículo en Inglés | MEDLINE | ID: mdl-17638702

RESUMEN

Enterobacter cloacae is an emerging clinical pathogen that may be responsible for nosocomial infections. Management of these infections is often difficult, owing to the high frequency of strains that are resistant to disinfectants and antimicrobial agents in the clinical setting. Multidrug efflux pumps, especially those belonging to the resistance-nodulation-division family, play a major role as a mechanism of antimicrobial resistance in gram-negative pathogens. In the present study, we cloned and sequenced the genes encoding an AcrAcB-TolC-like efflux pump from an E. cloacae clinical isolate (isolate EcDC64) showing a broad antibiotic resistance profile. Sequence analysis showed that the acrR, acrA, acrB, and tolC genes encode proteins that display 79.8%, 84%, 88%, and 82% amino acid identities with the respective homologues of Enterobacter aerogenes and are arranged in a similar pattern. Deletion of the acrA gene to yield an AcrA-deficient EcDC64 mutant (EcDeltaacrA) showed the involvement of AcrAB-TolC in multidrug resistance in E. cloacae. However, experiments with an efflux pump inhibitor suggested that additional efflux systems also play a role in antibiotic resistance. Investigation of several unrelated isolates of E. cloacae by PCR analysis revealed that the AcrAB system is apparently ubiquitous in this species.


Asunto(s)
Proteínas Bacterianas/genética , Proteínas Portadoras/genética , Farmacorresistencia Bacteriana/genética , Enterobacter cloacae/genética , Infecciones por Enterobacteriaceae/microbiología , Proteínas Bacterianas/metabolismo , Secuencia de Bases , Clonación Molecular , ADN Bacteriano/química , ADN Bacteriano/genética , Enterobacter cloacae/efectos de los fármacos , Genes MDR/genética , Vectores Genéticos , Humanos , Pruebas de Sensibilidad Microbiana , Datos de Secuencia Molecular , Plásmidos/genética , Porinas/genética , beta-Lactamasas/metabolismo
16.
Mol Microbiol ; 58(5): 1322-39, 2005 Dec.
Artículo en Inglés | MEDLINE | ID: mdl-16313619

RESUMEN

In environmental settings, biofilms represent the common way of life of microorganisms. Salmonella enterica serovar Enteritidis, the most frequent cause of gastroenteritis in developed countries, produces a biofilm whose matrix is mainly composed of curli fimbriae and cellulose. In contrast to other bacterial biofilms, no proteinaceous compound has been reported to participate in the formation of this matrix. Here, we report the discovery of BapA, a large cell-surface protein required for biofilm formation by S. Enteritidis. Deletion of bapA caused the loss of the capacity to form a biofilm whereas the overexpression of a chromosomal copy of bapA increased the biofilm biomass formation. We provide evidence that overproduction of curli fimbriae and not cellulose can compensate for the biofilm deficiency of a bapA mutant strain. BapA is secreted through a type I protein secretion system (BapBCD) situated downstream of the bapA gene and was found to be loosely associated with the cell surface. Experiments with mixed bacterial populations positive or negative for BapA showed that BapA minus cells are not recruited into the biofilm matrix. The expression of bapA is coordinated with that of genes encoding curli fimbriae and cellulose, through the action of csgD. Studies on the contribution of BapA to S. Enteritidis pathogenesis revealed that orally inoculated animals with a bapA-deficient strain survived longer than those inoculated with the wild-type strain. Also, a bapA mutant strain showed a significantly lower colonization rate at the intestinal cell barrier and consequently a decreased efficiency for organ invasion compared with the wild-type strain. Taken together, these data demonstrate that BapA contributes both to biofilm formation and invasion through the regular Salmonella infection route.


Asunto(s)
Proteínas Bacterianas/fisiología , Biopelículas/crecimiento & desarrollo , Regulación Bacteriana de la Expresión Génica , Salmonella enteritidis/fisiología , Salmonella enteritidis/patogenicidad , Secuencia de Aminoácidos , Animales , Proteínas Bacterianas/química , Proteínas Bacterianas/genética , Modelos Animales de Enfermedad , Femenino , Humanos , Ratones , Ratones Endogámicos BALB C , Datos de Secuencia Molecular , Sistemas de Lectura Abierta/genética , Salmonelosis Animal , Salmonella enteritidis/genética , Salmonella enteritidis/metabolismo , Virulencia
17.
Mol Microbiol ; 54(1): 264-77, 2004 Oct.
Artículo en Inglés | MEDLINE | ID: mdl-15458421

RESUMEN

Salmonella enterica serovar Typhimurium is capable of producing cellulose as the main exopolysaccharide compound of the biofilm matrix. It has been shown for Gluconacetobacter xylinum that cellulose biosynthesis is allosterically regulated by bis-(3',5') cyclic diguanylic acid, whose synthesis/degradation depends on diguanylate cyclase/phosphodiesterase enzymatic activities. A protein domain, named GGDEF, is present in all diguanylate cyclase/phosphodiesterase enzymes that have been studied to date. In this study, we analysed the molecular mechanisms responsible for the failure of Salmonella typhimurium strain SL1344 to form biofilms under different environmental conditions. Using a complementation assay, we were able to identify two genes, which can restore the biofilm defect of SL1344 when expressed from the plasmid pBR328. Based on the observation that one of the genes, STM1987, contains a GGDEF domain, and the other, mlrA, indirectly controls the expression of another GGDEF protein, AdrA, we proceeded on a mutational analysis of the additional GG[DE]EF motif containing proteins of S. typhimurium. Our results demonstrated that MlrA, and thus AdrA, is required for cellulose production and biofilm formation in LB complex medium whereas STM1987 (GGDEF domain containing protein A, gcpA) is critical for biofilm formation in the nutrient-deficient medium, ATM. Insertional inactivation of the other six members of the GGDEF family (gcpB-G) showed that only deletion of yciR (gcpE) affected cellulose production and biofilm formation. However, when provided on plasmid pBR328, most of the members of the GGDEF family showed a strong dominant phenotype able to bypass the need for AdrA and GcpA respectively. Altogether, these results indicate that most GGDEF proteins of S. typhimurium are functionally related, probably by controlling the levels of the same final product (cyclic di-GMP), which include among its regulatory targets the cellulose production and biofilm formation of S. typhimurium.


Asunto(s)
Proteínas Bacterianas/química , Proteínas Bacterianas/metabolismo , Biopelículas/crecimiento & desarrollo , Celulosa/metabolismo , Regulación Bacteriana de la Expresión Génica , Salmonella typhimurium/metabolismo , Secuencias de Aminoácidos , Proteínas Bacterianas/genética , Medios de Cultivo , Familia de Multigenes , Mutación , Salmonella typhimurium/clasificación , Salmonella typhimurium/genética , Salmonella typhimurium/crecimiento & desarrollo
SELECCIÓN DE REFERENCIAS
DETALLE DE LA BÚSQUEDA